Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 7.42
+0.07 (0.95%)
Aug 19, 2026, 11:57 AM CST
Pharmigene Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -52.27 | -73 | -82.86 | -72.65 | -42.72 | -23.43 |
Depreciation & Amortization | 23.36 | 24.81 | 23.69 | 22.81 | 19.65 | 15.02 |
Other Amortization | 0.89 | 0.89 | 0.29 | 0.06 | 0.12 | 0.18 |
Loss (Gain) From Sale of Assets | - | - | -0 | - | -0.4 | - |
Asset Writedown & Restructuring Costs | 1.6 | 5 | -0.13 | 2.05 | - | - |
Loss (Gain) From Sale of Investments | -1.12 | 2.46 | -14.46 | 0.51 | -0.21 | - |
Loss (Gain) on Equity Investments | 0.2 | 0.35 | 4.51 | 4.6 | 0.72 | 1.44 |
Provision & Write-off of Bad Debts | -2.66 | -1.64 | 3.95 | 0.07 | 0.59 | -1.44 |
Other Operating Activities | -1.37 | -0.47 | -0.28 | 0.45 | -0.09 | 1.76 |
Change in Accounts Receivable | 21.94 | -36.03 | 7.37 | 0.94 | -9.18 | -2.6 |
Change in Inventory | 9.32 | 9.45 | -26.24 | 1.13 | -9.87 | -7.73 |
Change in Accounts Payable | -16.02 | 7.41 | 6.47 | 0.76 | 4.32 | -0.01 |
Change in Unearned Revenue | 3.67 | 6.7 | 1.71 | -7.05 | 6.33 | -1.16 |
Change in Other Net Operating Assets | 8.3 | -12.93 | 5.94 | -6.21 | 7.28 | -1.33 |
Operating Cash Flow | -4.14 | -66.99 | -44.82 | -77.54 | -23.47 | -19.31 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -2.23 | -8.34 | -64.6 | -665.31 | -10.5 | -12.67 |
Sale of Property, Plant & Equipment | 3.87 | - | 2.12 | - | 0.93 | - |
Sale (Purchase) of Intangibles | 0.57 | -1.06 | -2.38 | -2.5 | -0.08 | -6 |
Investment in Securities | 37.18 | 2.99 | 87.02 | 9.27 | 19.1 | -62.83 |
Other Investing Activities | -1.3 | 0.4 | -1.07 | 1.11 | -4.55 | -0.78 |
Investing Cash Flow | 38.09 | -6.02 | 21.1 | -657.43 | 4.9 | -82.28 |
Short-Term Debt Issued | - | 96.16 | 12 | 70 | - | - |
Long-Term Debt Issued | - | - | 51 | 559.4 | - | - |
Total Debt Issued | 129.13 | 96.16 | 63 | 629.4 | - | - |
Short-Term Debt Repaid | - | -29.08 | -12 | -70 | - | - |
Long-Term Debt Repaid | - | -29.67 | -4.03 | -7.2 | -7.01 | -6.89 |
Total Debt Repaid | -112 | -58.75 | -16.03 | -77.2 | -7.01 | -6.89 |
Net Debt Issued (Repaid) | 17.13 | 37.41 | 46.97 | 552.2 | -7.01 | -6.89 |
Issuance of Common Stock | - | - | - | 175 | - | - |
Other Financing Activities | 0.69 | -0.18 | 0.31 | -0.56 | -2.17 | - |
Financing Cash Flow | 17.82 | 37.24 | 47.28 | 726.65 | -9.18 | -6.89 |
Foreign Exchange Rate Adjustments | 0.8 | -0.09 | 0.25 | -0 | 0.32 | -0.01 |
Net Cash Flow | 52.57 | -35.86 | 23.81 | -8.33 | -27.43 | -108.49 |
Free Cash Flow | -6.38 | -75.33 | -109.42 | -742.85 | -33.96 | -31.98 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -3.40% | -37.69% | -93.90% | -559.76% | -25.38% | -24.72% |
Free Cash Flow Per Share | -0.13 | -1.49 | -2.17 | -16.33 | -0.78 | -0.74 |
Levered Free Cash Flow | 17.27 | -51.56 | -96.68 | -719.91 | -19.55 | -24.35 |
Unlevered Free Cash Flow | 26.28 | -42.54 | -89.13 | -714.97 | -19.43 | -24.16 |
Cash Interest Paid | 15.09 | 15.09 | 11.97 | 7.08 | 0.2 | 0.31 |
Cash Income Tax Paid | - | -0.15 | 0.19 | 0.09 | 0.02 | 1.12 |
Change in Working Capital | 27.22 | -25.39 | 20.48 | -35.44 | -1.13 | -12.83 |